Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II Study of S-1 plus Cyclophosphamide for Advanced Breast Cancer
jRCTs031180296Phase 2Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tegafur and cyclophosphamide in breast cancer (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd. Primary endpoint: Response rate. Started Dec 2007; status: completed.
02
Drugs
tegafurcyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCTs031180296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180296.